Gainers Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre

Cytosorbents (NASDAQ: CTSO - Get Free Report) and Biomerica (NASDAQ: BMRA - Get Free Report) are bot

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.38) per share. This is a 44.93 percent incr

IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today reported its

Major M&A deals this week include: The Descartes Systems buys Tai, KKR nabs Ci FLAVORS, Skimmer

Biomerica, Inc. (NASDAQ:BMRA) ("Biomerica" or the "Company"), a developer and manufa

IRVINE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (“Biomerica” or the

Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.

Auto-renewing Master Services Agreement engages Biomerica's integrated development and manufacturing

Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented

Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced t

Company and Laboratory Partner Believe Properly Documented Claims Are Positioned for Payment Under E

— Represents Biomerica's First Commercial Entry into the Canadian Market for its Precision, Diagnost

Biomerica (NASDAQ:BMRA) reported quarterly losses of $(0.44) per share. This is a 8.33 percent incre

IRVINE, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (“Biomerica” or t

Biomerica (NASDAQ: BMRA - Get Free Report) is anticipated to post its results after the market close

First Commercial Order by Large Lab Chain: Biomerica has received its first commercial order for Hp

IRVINE, Calif., March 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider

UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great Britain Active

Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30%

Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1

Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price crossed below its 200-day moving aver

IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider

Operating Expenses Decline 4% Year-to-Date Balance Sheet Strengthens and Working Capital Improves by

Biomerica, Inc. (NASDAQ: BMRA - Get Free Report) saw a significant growth in short interest during t

Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s stock price passed below its 200-day moving avera

CMS is the single largest payer for healthcare in the United States, with Medicare responsible for a

IRVINE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider

Biomerica, Inc. (NASDAQ: BMRA - Get Free Report)'s share price passed below its 200-day moving avera

Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection • Portfo

Publication details large multicenter clinical trial demonstrating significant reductions in IBS sym

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionC

Biomerica, Inc. (NASDAQ:BMRA), a global biomedical company, announced today a marketing services arr

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation's Most Tru

Biomerica (NASDAQ:BMRA) reported $1.380 million in sales this quarter. This is a 23.63 percent decre

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigg